Treatment dermatitis. 2. Dermatitis medicamentosa.
D002751:Chlortetracycline / Q000009:adverse effects; D003875:Drug Eruptions; D006046:Gold / Q000009:adverse effects; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D008010:Lichen Planus / Q000139:chemically induced*; D008177:Lupus Vulgaris / Q000139:chemically induced*; D010634:Phenobarbital / Q000009:adverse effects; D010635:Phenolphthaleins / Q000009:adverse effects; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D013449:Sulfonamides / Q000009:adverse effects
D010635:Phenolphthaleins; D013449:Sulfonamides; D006046:Gold; D006493:Heparin; D002751:Chlortetracycline; D010634:Phenobarbital